A UCLA team created a biobank of sarcoma organoids from 126 patients, enabling rapid drug screening. The organoids retained tumor characteristics, allowing identification of effective FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback